A detailed history of Cape Investment Advisory, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 5,500 shares of MDXG stock, worth $51,040. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,500
Previous 5,500 -0.0%
Holding current value
$51,040
Previous $38.1 Million 14.72%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$5.7 - $9.14 $2,850 - $4,570
500 Added 10.0%
5,500 $48.2 Million
Q2 2023

Oct 12, 2023

BUY
$3.14 - $6.61 $3,140 - $6,610
1,000 Added 25.0%
5,000 $33.1 Million
Q1 2023

Oct 12, 2023

BUY
$2.97 - $4.81 $11,880 - $19,240
4,000 New
4,000 $13.6 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.05B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Cape Investment Advisory, Inc. Portfolio

Follow Cape Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cape Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cape Investment Advisory, Inc. with notifications on news.